Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold
Tomoyasu Ishikawa(Takeda (Japan)), Keiji Kamiyama(Takeda (Japan)), Satoshi Sogabe(Takeda (Japan)), Hiroshi Banno(Fujisawa City Hospital), Kathleen Aertgeerts(Fleet Science Center), Jason K. Yano(Fleet Science Center), Youichi Kawakita(Takeda (Japan)), Toshimasa Tanaka(Takeda (Japan)), Akiko Nakayama(Max Planck Institute for Heart and Lung Research), Hidenori Kamiguchi(Takeda (Japan)), Mami Oorui(Takeda (Japan)), Takahiko Taniguchi(Takeda (Japan)), Hiroshi Miki(Takeda (Japan)), Yoshikazu Ohta(University of Miyazaki), Masaki Seto(Takeda (Japan)), Toshiya Tamura(Takeda (Japan)), Noriyuki Habuka
Cited by 223
Related Papers
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
|Journal of Biological Chemistry|2011|441
Spatial regulation of VEGF receptor endocytosis in angiogenesis
|Nature Cell Biology|2013|272
Structure-Based Approach for the Discovery of Pyrrolo[3,2-<i>d</i>]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors
|ACS Medicinal Chemistry Letters|2012|171
Studies on Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline Derivatives and Their Anti-inflammatory Effect
|Journal of Medicinal Chemistry|1996|151